The Association of the British Pharmaceutical Industry (ABPI) is the trade association for the research-based pharmaceutical industry in the UK. Its primary objective is to involve itself with policy development and decision-making. Members include the large majority of pharmaceutical companies in the UK and it negotiates between both large and small companies that research and develop prescription medicines.
The ABPI has 150 members including the large majority of the research-based pharmaceutical companies operating in the UK. Our member companies develop, research, manufacture and supply more than 80 per cent of the medicines prescribed through the National Health Service (NHS).
Association of the British Pharmaceutical Industry (ABPI)
Food And Drug Administration (FDA), Health economics, National Service Frameworks (NSF), Global Health Observatory , Persistence, Drug usage/utilisation review (DUR), Preferred provider organisation (PPO), Phase IV trials, Alternative service providers (ASP), Big pharma, Health Care Financing Administration (HCFA) (US) , Investigational new drug (IND), Delegate, Commission on Human Medicines (CHM), i-Coach,